In the peak of the first COVID wave, Dr. Rajan Sankaran led a randomised, placebo-controlled trial in four top Pune hospitals, testing individualised classical homeopathy alongside standard care.

Mortality was 10x lower in the homeopathy group vs the placebo group (0.8% vs 8.8%) ICU Admission and need for ventilatory support were also significantly lower in the homeopathic group.

Peer-reviewed and published in Advances in Integrative Medicine (Elsevier)

This was a randomized, double blind, placebo-controlled trial which assessed the effectiveness of individualized homoeopathic treatment as an adjuvant to modern medicine in the management of COVID-19 using multivariate random-effects models and logistic regression models.

On days five and ten, the group that received homoeopathic treatment experienced reductions in symptoms, such as shortness of breath, cough, weakness, and fatigue...

Read more on ScienceDirect